SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-137238
Filing Date
2024-05-13
Accepted
2024-05-13 16:15:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d833587ddefa14a.htm DEFA14A 11701
2 GRAPHIC g833587g0511073627822.jpg GRAPHIC 8719
  Complete submission text file 0001193125-24-137238.txt   24925
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34186 | Film No.: 24939276
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)